HOME > TOP STORIES
TOP STORIES
-
BUSINESS Opdivo Gastric Cancer Filing Casts Cloud on Keytruda’s Sakigake Status
January 10, 2017
-
BUSINESS Takeda to Buy US Oncology Firm Ariad
January 10, 2017
-
REGULATORY MHLW to Regularly Compile Optimal Drug Use Guidelines from FY2017: Pharma Bureau Chief
January 6, 2017
-
REGULATORY From Regulatory Agency to Industry-Fostering Agency: Health Minister
January 5, 2017
-
REGULATORY Policymakers Rolling Up Their Sleeves to Embody Drug Pricing Overhaul
January 1, 2017
-
REGULATORY AMED Plans to Introduce Medical-Economic Viewpoints for Its R&D Support
December 28, 2016
-
BUSINESS 40 Billion Yen Sales for Oncology Business in FY2020 Achievable: Daiichi Sankyo
December 27, 2016
-
ORGANIZATION Novo’s Ole Moelskov Bech to Helm EFPIA Japan from January
December 26, 2016
-
BUSINESS Sumitomo Dainippon to Buy US Hematology Startup Tolero
December 22, 2016
-
BUSINESS Ono Slashes Opdivo Sales Outlook on 50% Price Cut
December 22, 2016
-
REGULATORY Quarterly Price Reviews for Indication-Added Drugs Likely to Get Underway in FY2017, Annual Scheme in FY2018: Officials
December 21, 2016
-
BUSINESS New Technologies to Cure Cancers, Help Reduce Medical Expenditure: Report
December 21, 2016
-
REGULATORY Four Ministers Map Out Basic Policy for Drug Pricing Revamp
December 21, 2016
-
REGULATORY Basic Policy for Drastic Reform of Drug Pricing System
December 20, 2016
-
BUSINESS Keytruda Gets NSCLC Nod Both in 1st-Line, 2nd-Line Settings
December 20, 2016
-
ACADEMIA New Lung Cancer Guidelines to Give Keytruda Grade A Recommendation as First-Line Treatment
December 19, 2016
-
BUSINESS Fujifilm to Acquire Takeda’s Reagent Unit for 155 Billion Yen
December 16, 2016
-
BUSINESS Nippon Kayaku Introduces “MSLs” to Strengthen Detailing for Oncology Generics, Biosimilars, and Products in Development
December 16, 2016
-
ORGANIZATION JMA Wants Adjustment Rate as High as 5%: Yokokura
December 15, 2016
-
REGULATORY PD-L1 Expression Testing Won’t Be a Must for Opdivo, but Clarification Needed: Chuikyo
December 15, 2016
ページ
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
